Back to Contents
Item 2. Management’s Discussion and Analysis or Plan of Operation.
Dialog Group, Inc. (formerly IMX Pharmaceuticals, Inc.) (“Company” or “DGI”) is a publicly traded corporation (OTCBB:DLGG) with headquarters in New York City and offices in Burbank, California; Sunrise, Florida; Houston, Texas and Cambridge, United Kingdom.
During this quarter, the Company completed its acquisition of Healthcare Dialog, Inc. (“HCD”) and IP2M, Inc. (“IP2M”). At the beginning of the second quarter, DGI completed the acquisition of Healthcare Horizons, Inc (“HCH”) and the assets of Azimuth Target Marketing, Inc. As a result, DGI can conceive and implement a comprehensive program for its health care and other clients and execute it with DGI’s specialized data bases and services and unique channel of communication. The new, united company combines depth of healthcare knowledge and broad strategic and creative services with the information and channels to quickly achieve their clients’ objectives.
Through its four operating divisions, DGI provides its clients a suite of products that are available as either a turnkey solution or as a component for their marketing plan. DGI provides proprietary online and offline support for the healthcare, small business, telephone service bureau, financial services and direct marketing industries in the United States, and software in the United Kingdom. Current and past healthcare clients include Novartis AG, Schering-Plough, GlaxoSmithKline, Johnson and Johnson, Boehringer-Ingelheim and Forest Laboratories. Partners and strategic relationships include the United States Post Office, Clear Channel Communications, ABC Radio, McGraw-Hill Television, Acxiom, Claritas, National Association of Insurance and Financial Advisors, and Microsoft.
Description of Healthcare Dialog, Inc. (HCD)
Healthcare Dialog, Inc. is a leading provider of relationship marketing communications services to the healthcare industry. Healthcare Dialog provides pharmaceutical companies with a suite of integrated healthcare-specific campaign creation and management capabilities — including strategic and creative services, interactive communication services, patient/consumer target identification, and database enhancement and management services. Combining these services into 5 intergrated programs, Healthcare Dialog creates, launches, and continually upgrades a wide range of targeted and highly customizable direct and interactive marketing campaigns. Clients rely on Healthcare Dialog to help establish and build more valuable and longer lasting relationships with physicians, patients, and consumers over a broad array of permission-based contact points, including Internet websites, opt-in e-mails, digital, on-demand print, direct mail and telemarketing. Healthcare Dialog provides clients with comprehensive healthcare expertise, access to databases of more than 100 million households, experience in scalable mass personalization distribution technology, capabilities in syndicated marketing campaigns and track record of successfully delivering professional results.
Past and present Healthcare Dialog clientele includes global pharmaceutical leaders such as Novartis AG and Schering-Plough Corp. and healthcare product retailers such as
Back to Contents
the Rite Aid drugstore chain. Healthcare Dialog partners with numerous client-side brand teams and sales force management teams and wide ranging experience with both mass market and niche client brands, including such household names as Allegra® and Coppertone®. Because of it’s in-house content development and media production capabilities, Healthcare Dialog also provides its services to other industries, including Insurance, Hotel and Hospitality Services, etc., including companies such as Assurant, Progressive Insurance and Marriott Vacation Clubs.
IP2M is a marketing company that has developed a unique marketing platform in healthcare that integrates radio, television, and the Internet to assist clients in targeting consumers. IP2M offers a national solution using the existing loyalty of the local radio and television stations to drive traffic to the client's content and advertising within the IP2M platform.
IP2M offers its clients
• Specialized advertising, marketing, and promotional programs to targeted consumers at competitive rates
• Broad coverage through exclusive content partnerships with leading media companies (including Clear Channel Radio, Morris Communications, Nassau Media Partners, Hispanic Broadcasting, Granite Broadcasting Corp. and through Internet Broadcasting Systems (IBS) with Hearst Television, Post Newsweek Television, McGraw Hill Television, and Freedom Television.)
• Proprietary content and distribution technology.
Typically, IP2M will provide healthcare-related content to a media partners’ branded website and sell the entire “package” of radio, television and online media to its healthcare customers. Through its media partnerships, IP2M has immediate access to over 1,000 radio and television stations and an audience in excess of 100,000,000 people. Each of these radio and television stations is sending consumers to their websites. Thus, IP2M receives the benefit of its media partners’ existing website viewers. IP2M’s unique technology allows it to distribute different content and advertising to each site based on market and demographics in a scalable manner. Through its network of thousands of websites, radio and television stations, IP2M is able to reach and specifically target millions of consumers on a nation-wide basis and provide customization based on product and market segmentation. As IP2M integrates all media, it has become a "one stop shop" offering clients cost-efficiencies that they cannot find anywhere else in the $15 billion healthcare advertising market.
IP2M tracks results, supplies objective performance measures, and is able to maximize its clients’ return on investment. Clients have found IP2M’s health channel to be 5 times more effective than print media alone and 10 times more effective than the Internet without any broadcast support in directing viewers to the clients’ own website.
IP2M’s clients for 2002 included Roche Pharmaceutical, Pfizer, GlaxoSmithKline, Depuy Johnson & Johnson, Takeda Pharmaceuticals, Novartis, St Luke's Hospital and Quality Medical
Back to Contents
Management. Each client has extended its campaign, engaged IP2M for additional brands, or placed IP2M on its 2003 media plan.
Description of HCH and Azimuth
HCH and Azimuth are owners and distributors of demographic, disease, and healthcare information. Their permission-based data acquisition and management system offers their clients a superior level of market intelligence providing them with an unprecedented opportunity to market on a one-to-one basis.
Description of TDMI and Findstar
TDMI is a US company that provides businesses the ability to target, create, print and execute a direct marketing campaign online from their desktop computer. TDMI offers online subscribers access to consumer and business databases containing opt-in information on over 100 million US consumers that can be searched both geographically, demographically, income, and other personal profiles. In addition to its subscription products TDMI offers thousands of specialized consumer lists from the nation’s largest data compilers including Acxiom, InfoUSA, and Equifax. To complement these data services TDMI has made available to its customers the ability to use its online mailing solutions to execute direct mail campaigns from the desktop.
TDMI Partners include: United States Postal Service (which has access to approximately 250 million households and 16 million businesses); Microsoft, a worldwide leader in software, services and Internet technologies for personal and business computing; Avery Dennison, a global leader in label & office products; Claritas, a leading provider of marketing information solutions, including marketing databases, industry-expertise, data access and analysis; U.S.A. Direct, a provider of direct mail production services including design, printing, inserts; National Association of Insurance and Financial Advisors (NAIFA) consisting of approximately 70,000 insurance and financial advisors worldwide; National Restaurant Association, the leading business association for the restaurant industry, comprised of 858,000 restaurants; Artisoft, a provider of computer telephony systems; and Interactive Intelligence, a developer of enterprise software for call c enters.
TDMI’s direct mail, mailing services, and telemarketing products are specifically tailored to provide a cost-effective and powerful direct marketing solution for new customer acquisition and customer retention to the more than 20 million small and medium size businesses in the United States. Products and services are delivered from the Company’s web site and sales offices in the U.S.
In April 2001, TDMI completed the acquisition of DirectMailQuotes, LLC (“DMQ”) to further expand into direct product sales to the letter shop channel. DMQ, through its MailMogul professional brand, provides mailing list acquisition, mailing supplies, National Change of Address (NCOA) for data cleansing and enhancement and the industries premier lead generation service, Directmailquotes.com, for the letter shop channel. As DMQ was also one of the five USPS partners, the acquisition consolidated TDMI’s position as the Postal Services leading affiliate.
Back to Contents
Findstar plc is a sales led organization with telemarketing capabilities currently selling and distributing on an exclusive basis the Panda Software anti-virus software and products in the UK.
Panda UK holds the exclusive distribution license for the sale, marketing, and distribution of Panda Software products through out England, as well as in Scotland and Wales. The licence has a five-year term ending in January 2005 with an option for an additional two years. The license may be renewed for additional periods.
Panda UK was established in 1999 to acquire the exclusive licence for Panda Software products. Panda Antivirus was established in 1999 as a reseller of Panda Software products under an arrangement with Panda UK. Findstar was incorporated in January 2001 as the holding company for Panda UK and Panda Antivirus.
Back to Contents
Results of Operations
The Company’s consolidated operations reflected in this quarter’s financial statements include all four subsidiaries, HCD, IP2M, Findstar, and TDMI. The operations conducted by HCH and Azimuth are not included as they were acquired after the end of this quarter. The consolidated results of operations for the quarter ended March 31, 2003 are being presented on a pro-forma basis because management believes that the results of operations for the three months ended March 31, 2003 and 2002 are more meaningful then the accrual results of operations that include only the month of March 2003 for the accounting acquiree.
Healthcare Dialog
For the three months ended March 31, 2003, HCD’s total consolidated revenues were approximately $670,926 as compared to approximately $1,110,790 for the same period ended March 31, 2002, a decrease of about $439,864 or about 40%. The reduction due to two major marketing programs the company sold to a pharmaceutical client being in the production stage simultaneously. These programs are ongoing in the first quarter of 2003, but are now in the management stage which produces less in revenue, but at higher margins. The company’s qd.online subsidiary in quarter one 2002 produced $156,325 in revenue compared to none during the same period of 2003.
HCD’s gross margin on sales for the first quarter of 2003 was almost 48%, up 5 point from the 2002 level of 43%.
HCD’s consolidated total operating expenses were approximately $242,596 for the three months ended March 31, 2003. This compares with approximately $1,438,057 for the same period ended March 31, 2002. The decrease between periods resulted from management’s decision in 2002 to write down $624,859, $300,000 and $95,067 in “loss on goodwill impairment”, “loss on website impairment” and “loss on fixed assets disposal” respectively.
For the three months ended March 31, 2003, HCD’s consolidated net gain from operations was approximately $91,129. This represents an improvement from net losses of about $(897,404) in the period ending March 31, 2002. While sales during this period were off, the write down of assets in 2002 combined with reduced marketing and administrative expenses combined to improve the bottom line by almost $1 million.
IP2M
For the three months ended March 31, 2003, IP2M’s net revenues were approximately $634,000 as compared to approximately $483,000 for the same period ended March 31, 2002, an increase of about $150,000 or over 30%. The increase is due to customers renewing their business or expanding their campaign combined with new sales resulting from increased acceptance of IP2M’s programs.
Back to Contents
IP2M’s gross margin on sales for the first quarter of 2003 was almost 35%, as compared to 39% during this quarter in 2002. This is attributable to the relatively faster growth of IP2M’s media purchasing division, which has a smaller gross margin.
IP2M’s consolidated total operating expenses were approximately $265,000 for the three months ended March 31, 2003. This compares with approximately $684,000 for the same period ended March 31, 2002. Decreasing the core personnel and outsourcing additional work to meet our clients’ demands and expanding business accomplished this. Additionally, with the merger, the need for investment banker fees has decreased as well as the professional fees associated with such activities.
For the three months ended March 31, 2003, IP2M’s consolidated net loss from operations was approximately $(44,000). This represents an improvement from net losses of about $(492,000) in the quarter ended March 31, 2002. This is due to improvements in optimizing our platform, increasing sales, and planning for a consolidation with Healthcare dialogue.
TDMI:
TDMI’s consolidated revenues (including DMQ) were approximately $912,000 for the three months ended March 31, 2003 as compared to approximately $776,000 for the same period ended March 31, 2002, an increase of about $136,000 or more than 15%. The improved results, which occurred despite the dislocations inherent in the relocation of TDMI’s sales offices, are due to new customers as well as increased revenues from existing customers and the introduction and rollout of the batch version of TDMI’s DigitalData service.
TDMI’s gross margin on sales for the first quarter of 2003 was almost 48%, approximately the same during this quarter in 2002.
TDMI’s consolidated total operating expenses were approximately $569,000 for the three months ended March 31, 2003. This compares with approximately $994,000 for the same period ended March 31, 2002. The decrease between periods, quarter to quarter at a time of greatly overall sales was accomplished by a reduction of executive positions, consolidation of staff, specifically technology and management staffing, and closure of offices.
For the three months ended March 31, 2003, TDMI’s consolidated net loss from operations was approximately $(140,000). This represents an improvement from net losses of about $(690,000) in the period ending March 31, 2002. Increased sales during this period combined with reduced salary, marketing, and administrative expenses continued to improve the bottom line.
Findstar:
For the three ended March 31, 2003, the Findstar’s consolidated net sales were approximately $462,000 as compared to $222,000 for the same period ended March 31, 2002. This increase, representing a doubling of sales, is attributable to the aggressive approach of the management
Back to Contents
in opening up new sales routes and the continuing expansion of channel sales through resellers and distributors.
The Findstar’s gross profit margin for the three months ended March 31, 2003 was approximately 62%, almost the same as the 63.8% margin for the three months to March 31, 2002.
The Findstar’s total operating expenses were approximately $295,000 for the three months ended March 31, 2003 compared with $274,000 for same period in 2003 an increase of less than 8% while sales were increasing by 100%. This is because of a change in selling methods resulting in a reduction in commissions paid and a minimal increase in staff to service the increased turnover.
As a result of these actions, Findstar’s net (loss) from operations for the three months ended March 31, 2003 was reduced to approximately $(7,615) from $(132,914) for the three months to March 31, 2002.
DGI Administrative Costs:
DGI’s central administrative costs reflect the growth of the Company’s financing and management responsibilities. They were $398,000 during the first quarter of 2003. In addition, during 2003, over $48,000 in interest costs were incurred. Administrative costs for the same period during 2002 were $217,000.
Liquidity & Capital Resources
DGI had a consolidated working capital deficit of approximately $(3,940,000) on March 31, 2003 as compared to a deficit of approximately $(3,121,000) at December 31, 2002. The year end deficit did not include the December 31, 2002 working capital deficits of the two acquired companies, HCD and IP2M. Their working capital deficits as year end were approximately $(908,000) and $(1,379,000), respectively. During the quarter ended March 31 2003, the Company raised over $870,000 through the sale of its stock.
On March 31, 2003, HCD’s financial condition included a working capital deficit, of about $(798,000) as compared to a deficit of approximately $(908,000) at December 31, 2002.
At the end of March, IP2M had a working capital deficit of approximately $(258,000) as compared to a deficit of about $(1,379,000) on December 31, 2002.
On March 31, 2003, Findstar’s consolidated financial condition included a working capital deficit, excluding inter-company items, of about $(469,000) as compared to a deficit of approximately $(764,000) at December 31, 2002.
At the end of March, TDMI had a working capital deficit of approximately $(1,906,000) as compared to a deficit of about $(1,908,000) on December 31, 2002.
Back to Contents
Inflation
Inflation rates in the United States have not had a significant impact on operating results for the periods presented.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this item and elsewhere in this report regarding matters that are not historical facts are forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such forward-looking statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. All statements that address operating performance, events or developments that management expects or anticipates to incur in the future, including statements relating to sales and earnings growth or statements expressing general optimism about future operating results, are forward-looking statements. The forward-looking statements are based on management’s current views and assumptions regarding future events and operating performance. Many factors could cause actual results to differ materially from estimates contained in management’s forward-looking statements. The differences may be caused by a variety of factors, including but not limited to adverse economic conditions, competitive pressures, inadequate capital, unexpected costs, lower revenues and net incomes and forecasts, the possibility of fluctuation and volatility of the Company’s operating results and condition, inability to carry out marketing and sales plans, and loss of key executives, among other things.
Item 5. Election of Director
On April 7, 2003, Stephen Dean resigned as a Director and as the Chairman of the Board of Directors. He will not be replaced until the Annual Meeting on May 28, 2003 at which time two independent directors will be elected. Mr. Dean’s resignation was not the result of any policy dispute.
Back to Contents
Item 6. Exhibits and Reports on Form 8-K
Exhibit Number | Description |
| |
None | |
A report on Form 8-K (items 2 and 5) reporting on the acquisition of Healthcare Dialog, Inc. and IP2M, Inc. was filed on March 14, 2003.
A report on Form 8-K/A (items 2 and 7) containing the financial statements required by the acquisition of Healthcare Dialog, Inc. and IP2M, Inc. (initially reported on a Form 8-K filed on March 14, 2003) was filed on May 15, 2003.
Back to ContentsPart II. Other Informati on
Items 1, 3, 4, and 5 are omitted as they are either not applicable or have been included in Part I.
Item 2 (c) Recent Sales of Unregistered Securities
Acquisition Transactions
Upon consummation of the merger between Healthcare Dialog and a wholly owned subsidiary of DGI, the Registrant issued 30,075,219 shares of its Common and 183,235 shares of its Class B-1 Preferred to the present Healthcare Dialog shareholders. This is intended to equal the number of outstanding before the transaction plus an estimated number of shares that will be issued to complete DGI’s financing program.
The amended agreement called for an additional $1,650,000 in financing. Cater Barnard has agreed to assure that at least $650,000 will be raised and has agreed to post negotiable collateral against its obligation to purchase up to 3,513,514 shares of DGI Common Stock. On April 7, 2003 Cater Barnard was released from this obligation in exchange for the cancellation of 3,500,000 of its shares of DGI Common Stock
Upon consummation of the merger between IP2M and a wholly owned subsidiary of DGI, the Registrant issued 6,191,029 shares of its Common Stock and 44,312 shares of its Class B-1 Preferred to the present IP2M shareholders. This is intended to approximate ten (10%) percent of the number of shares of each class outstanding after these transactions. After the closing, the IP2M shareholders may share approximately 700,000 additional shares of Common Stock if certain financial goals are met. In addition, upon the consummation of the HCH/Azimuth acquisition, an additional 589,710 shares of Common Stock and 3,593 shares of Class B-1 Preferred Stock were issued to the IP2M shareholders. All the shares issued for the IP2M owners are held in escrow to secure the accuracy of their representations.
Both of these transactions were accomplished by means of a statutory merger. Pursuant to Rule 145, the securities issued were treated as restricted securities and were, therefore, subjected to stop orders with the Company’s transfer agent and the certificates include a legend indicating that they may not be transferred without registration or the existence of an exemption. Therefore, this issuance was exempt from registration under the provisions of Section 4(2) of the Securities Act.
At the end of the previous fiscal year, as a condition precedent to the acquisitions, Cater Barnard agreed to convert all of Dialog Group’s debt to it into Common Stock. In exchange for cancellation of the principal and all interest due on the Company’s notes dated June 27, 2002, August 1, 2002, and September 3, 2002 and a portion of the year end open accounts aggregating $2,354,815 on the Company’s records, DGI issued 9,274,280 shares of its Common Stock to Cater Barnard.
Back to Contents
This transaction is exempt from the registration requirements of Section 5 of the Securities Act under Section 4(2) of the Securities Act it did not involve a public distribution of the Company’s securities.
Regulation S Transactions
On October 4, 2002 the Company authorized Starz Investments Limited to sell up to 10,000,000 shares of its Common Stock to investors located outside of the United States. The shares were offered pursuant to an exemption from registration afforded by Regulation S to the Securities Act of 1933. Shares sold pursuant to Regulation S are deemed restricted and may not be sold to any U.S. Person (as that term is defined in the Regulation) for a period of one (1) year from date of sale. Last year 181,465 shares were issued to the nominee designated by Starz. The purchase price for that lot was approximately $35,000. During the quarter, an additional 3,470,450 shares were issued for a total consideration of $524,244. Since the end of the quarter, 1,892,542 additional shares have been issued for a total of $144,268.
On March 28, 2003 the Company authorized Californian Securities S.A to sell up to 4,000,000 shares of its Common Stock outside the United States, also pursuant to Regulation S, at a price of $0.06 per share. Through the end of the quarter, no shares had been issued. Since the end of the quarter, 3,550,752 shares have been sold for a total of $213,337.
Bridge Loan Transaction
In connection with a bridge loan associated with the closing of the HCD and IP2M acquisition, DGI issued 1,100,000 shares of its Common Stock to Californian Securities, S.A. and granted A Street Capital Corp. a warrant to purchase 350,000 of its shares at a price of $0.05 per share.
Related Purchases
In connection with the acquisitions described above, 13 individuals who are associated with the principal owners of IP2M and who represented themselves as accredited investors purchased 2,333,333 shares of Common Stock for a total purchase price of $335,000. In addition, Peter V. DeCrescenzo, Cindy Lanzendoen, Vincent DeCrescenzo, Sr., and Robin Smith, all officers of the acquired companies, acquired 410,933, 233,333, 344,333, and 250,000 shares of Common Stock, respectively. The purchase price for these shares was $410.93, $233.33, $344.33, and $250.00, respectively. All of these transactions were exempt from registration under the Securities Act pursuant to section 4(2) because they were private sales to individuals who were not intending to redistribute the securities. All purchasers agreed to the placement of a restrictive legend on their certificates and the filing of a stop order with the Company’s transfer agent.
Other issuances
During January, 2003, one additional investor purchased 20,000 shares of the Company’s Commons Stock at 0.50 per share. He represented himself in writing to be an accredited investor
Back to Contents
who was purchasing these shares for his own investment and agreed to restrictions on resale placed with the Company’s transfer agent and the printing of a legend on his certificate. Because of these factors, this sale is exempt from registration under the Securities Act as not involving a public distribution under section 4(2).
On November 1, 2002 the Company entered into consulting agreements with Kuma Consulting, Inc. Under these agreements the Company agreed to pay Kuma $47,500 and to issue a total of 400,000 shares of its common stock for Kuma’s consulting services. $47,500 has been paid and 338,000 shares had been issued to Kuma or its designees. The remaining 62,000 shares were issued to Kuma during the second quarter. The shares issued to Kuma are exempt from registration under section 4(2) of the Securities Act as private transactions because they were acquired for investment and are subject to stop orders and restrictive legends.
On February 12th, 2003 the Company agreed to issue 200,000 shares to Knightsbridge Capital for consulting services. After the close of the quarter, 67,600 shares were issued to Knightsbridge’s designees. The issuance of these shares is exempt from registration under section 4(2) of the Securities Act as a private transaction because the shares were acquired for investment and the certificates bear restrictive legends and are subject to stop orders.
The proceeds of all shares issued for cash were used for general business purposes.
Conversions
During this quarter, a former TDMI shareholder converted 8,250 shares of Class B Preferred Stock into 330,000 shares of Common Stock. After the close of the quarter, Cater Barnard converted all its 142,810 shares of Class B Preferred Stock into 5,712,400 shares of Common Stock and another former TDMI shareholder converted 343 shares of Class B Preferred Stock into 13,720 shares of Common Stock. All the certificates issued upon conversion bore Securities Act legends and stop orders have been recorded with the transfer agent. These transactions were exempt from registration under Section 4(2) of the Securities Act of 1933 because they did not involve any distribution of DGI’s securities to the public.
5
Back to Contents
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has caused this quarterly report on Form 10-QSB to be signed in its behalf by the undersigned thereunto duly authorized on the 20th day of May 2003.
DIALOG GROUP, INCBy: /s/ Peter V. DeCrescenzo
Peter V. DeCrescenzo, Chairman, President & CEO
CERTIFICATIONS
Chief Executive Officer
I, Peter V. DeCrescenzo, certify that:
1. | I have reviewed this annual report on Form 10-QSB of Dialog Group, Inc.; |
2. | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; |
b) | evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and |
c) | presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
Back to Contents
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and |
5. | The registrant’s other certifying officers and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 20, 2003
/s/ Peter V. DeCrescenzo
Peter V. DeCrescenzo, CEO
Chief Financial Officer
I, Vincent DeCrescenzo, Sr., certify that:
1. | I have reviewed this annual report on Form 10-QSB of Dialog Group, Inc.; |
2. | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; |
b) | evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and |
c) | presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
Back to Contents
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions); |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and |
6. | The registrant’s other certifying officers and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 20, 2003
Vincent DeCrescenzo
Vincent DeCrescenzo, Sr. CFO